Adjuvants and Vaccine Formulation
The course provides an overview of State-of-the-art adjuvant systems and addresses the preclinical and clinical development of adjuvanted vaccines.
15 of December 2021
21-24 March 2022 (4 days)
Vaccine Formulation Institute (VFI), Geneva, Switzerland
Participant Nr.: 10
Combination of lectures, discussion rounds, and group work on thematic case studies. Topics: Adjuvant systems, such as aluminum salts, oil-in-water emulsions, water-in-Oil emulsions, liposomes, PLGA particles, virosomes, QS21, TLR ligands) and preclinical and clinical development of adjuvanted vaccines.
Good understanding of the different adjuvant systems and of the challenges of preclinical and clinical development of adjuvanted vaccines.
Who should apply
Scientists and professionals involved in research and development of vaccines who are working with – or planning to work with – adjuvants.
Applicants should have a BSc or MSc, or have demonstrable vaccine-related research experience.
Accommodation will be provided. Travel Costs are not included.
The course will be organized in collaboration with ENOVA, the European Network of Vaccine Adjuvants. ENOVA will sponsor 10 additional participants, selected via the separate ENOVA call for applications.
*Due to COVID19 related delays call and training modules' schedule may be subject to change.